RS
NVO

R Squared’s Novo Nordisk NVO Stock Holding History

R Squared’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$395K Buy
10,756
+912
+9% +$43.2K 0.22% 132
2025
Q4 		$501K Buy
+9,844
New +$503K 0.23% 114

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

R Squared's NVO Position: Q1 2026 in Review

R Squared increased its Novo Nordisk (NVO) stake by 9.3% in Q1 2026, buying an estimated $43.2K and bringing the position to 10,756 shares worth $395K. The position accounts for 0.22% of the portfolio, ranked #132.

R Squared first reported a position in NVO in Q4 2025 and has held it in 2 quarters since. The position peaked at $501K in Q4 2025. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • R Squared held 10,756 shares of Novo Nordisk worth $395K as of Q1 2026.
  • R Squared bought 912 Novo Nordisk shares in Q1 2026, an estimated $43.2K.
  • Novo Nordisk made up 0.22% of R Squared's portfolio in Q1 2026, its #132 holding.
  • R Squared first reported a position in Novo Nordisk in Q4 2025 and has held it in 2 quarters since.
  • R Squared's Novo Nordisk position peaked at $501K in Q4 2025.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.